OTCMKTS:IDRSF

Idorsia (IDRSF) Stock Price, News & Analysis

Idorsia logo
$4.70 0.00 (0.00%)
As of 11/17/2026

About Idorsia Stock (OTCMKTS:IDRSF)

Advanced

Key Stats

Today's Range
$4.70
▼
$4.70
50-Day Range
$4.70
▼
$6.15
52-Week Range
$3.50
▼
$8.19
Volume
N/A
Average Volume
9,090 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Idorsia Ltd. is a Swiss biopharmaceutical company focused on discovering, developing and commercializing medicines for diseases with significant unmet medical needs. Its research activities span areas including cardiovascular disease, central nervous system disorders, immunology and rare diseases. The company operates from its headquarters in Allschwil, Switzerland, and serves international pharmaceutical markets through its own commercial operations and collaboration arrangements.

Idorsia’s commercial portfolio includes QUVIVIQ (daridorexant), an orexin receptor antagonist used to treat insomnia in eligible adults, and PIVLAZ (clazosentan), a therapy intended to reduce the risk of cerebral vasospasm and related complications following aneurysmal subarachnoid hemorrhage. The company has also developed aprocitentan, marketed as TRYVIO in the United States for certain adults with treatment-resistant hypertension.

Idorsia was established in 2017 following the acquisition of Actelion by Johnson & Johnson, with Actelion’s discovery and early-stage research operations forming the foundation of the new company. Idorsia was founded by Jean-Paul Clozel and Martine Clozel and is led by Jean-Paul Clozel, who has served as chief executive officer. The company continues to advance a pipeline of internally discovered medicines alongside its marketed products.

AI Generated. May Contain Errors.

Receive IDRSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Idorsia and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDRSF Stock News Headlines

Idorsia Ltd (IDRSF) Shareholder/Analyst Call Transcript
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More Headlines

IDRSF Stock Analysis - Frequently Asked Questions

Idorsia's stock was trading at $5.25 on January 1st, 2026. Since then, IDRSF stock has decreased by 10.5% and is now trading at $4.70.

Shares of IDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Idorsia investors own include Lakefront Biotherapeutics American Depositary Shares (LKFT), Moderna (MRNA), Tesla (TSLA), Workhorse Group (WKHS), Transocean (RIG), Air Canada (AC) and adidas (ADS).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:IDRSF
CIK
N/A
Fax
N/A
Employees
487
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:IDRSF) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners